Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure
Open accessThe DOI matches its Crossref record.
Abstract
Sir, In Belgium, the vast majority of salmonellosis is caused by the serovars Enteritidis and Typhimurium, which represent together more than 80% of the isolates. Salmonella enterica serovar Kentucky is a very uncommon serovar that represented 0.02% to 0.5% of the total isolates during the last decade, but 0.8% in 2006. Indeed, this serovar showed a usual increase in Europe during the third quarter of 2006 with several of them acquired during travels to Northeast Africa and Turkey.1 We report here the first Belgian case of a travel-acquired multidrug-resistant Salmonella Kentucky resulting in a treatment failure because of a high resistance level to ciprofloxacin and secondarily acquired resistances to extended-spectrum cephalosporins (ESCs) and trimethoprim + sulfamethoxazole (co-trimoxazole). In September 2005, a 77-year-old healthy man on a cruise along the North Africa coast developed febrile diarrhoea a few hours after a meal (chicken couscous and dates) in a small restaurant on the Libyan coast. Consequently, he was admitted for 48 h in a hospital in Cairo (Egypt) and treated with intravenous (iv) mezlocillin followed by co-trimoxazole given orally for a few more days whereby he slowly recovered. Two weeks after his return to Belgium, he presented again with febrile diarrhoea and arthritis of the wrist. After examination of his stool, the Clostridium difficile stool toxin test was positive and Salmonella Kentucky was isolated. The Salmonella isolate was susceptible to co-trimoxazole, but resistant to ampicillin, tetracycline, streptomycin, sulphonamide, nalidixic acid and ciprofloxacin (full resistance) by the standard disc diffusion susceptibility method according to CLSI (formerly NCCLS) guidelines.2 MICs of nalidixic acid and ciprofloxacin determined by standard agar doubling dilution were >1024 and 4 mg/L, respectively. In order to identify the mechanisms responsible for ciprofloxacin resistance, the quinolone resistance-determining regions of gyrA, gyrB, parC and parE were amplified and sequenced as described previously.3 Two mutations leading to substitutions Ser-83 → Phe (TCC → TTC) and Asp-87 → Asn (GAC → AAC) were identified in gyrA. An additional substitution was observed in parC resulting in Ser-80 → Ile (AGC → ATC). In the presence of the efflux pump inhibitor Phe-Arg-β-naphthylamide, the MIC of ciprofloxacin was reduced 4-fold, suggesting that an active efflux mechanism was also present. The involvement of the AcrAB-TolC efflux system was determined by measuring AcrA expression with a method described previously.4 However, the expression of the AcrA protein was equivalent to the baseline production in a susceptible reference strain. As ambulatory treatment, the patient received a prescription for co-trimoxazole (160 mg of trimethoprim/800 mg of sulfamethoxazole, twice a day) and metronidazole (500 mg, three times a day) given orally for 10 days. One week after drug discontinuation, diarrhoea and arthritis reappeared. A new stool culture was again positive for Salmonella Kentucky. In addition to the profile observed in the first isolate, this strain presented additional resistances to co-trimoxazole (MIC > 256 mg/L) and ESCs [cefotaxime MIC > 256 mg/L, ceftriaxone MIC > 256 mg/L, cefepime MIC = 16 mg/L and showed increased MIC of ceftazidime (4 mg/L)]. The strain was susceptible to meropenem (MIC = 0.5 mg/L). The C. difficile toxin test was again positive for the second stool culture. As diarrhoea persisted, the patient was this time admitted for iv treatment with meropenem (1 g three times a day for 5 days) combined with oral vancomycin (250 mg three times a day for 10 days). Although the stool cultures performed during the hospitalization remained positive for the C. difficile toxin, the diarrhoea disappeared but abdominal pain persisted. Therefore, a colonoscopy was performed and showed non-specific rectal ulcerations. Abdominal pain was resolved with mesalazine enema treatment. To determine the nature of produced β-lactamases provoking the cephalosporin resistance, PCR amplifications specific for β-lactamase genes of the TEM, SHV and CTX-M families were performed as described previously.5 Only the CTX-M consensus PCR assay gave the expected PCR fragment (545 bp). Sequence analysis of the PCR product revealed 100% identity with the blaCTX-M-1 sequence (GenBank accession number X92506). To determine the genetic relatedness between the two consecutive Salmonella Kentucky isolates, an XbaI PFGE analysis was performed (Figure 1). Two very similar profiles were observed differing only by one additional band of ∼100 kb in the cephalosporin-resistant strain. To the best of our knowledge, this is the first isolation of a Salmonella resistant to the three antibiotic classes recommended to treat invasive salmonellosis (fluoroquinolones, ESCs and co-trimoxazole) and associated with a treatment failure. The existence of ciprofloxacin-resistant but ESC-susceptible Salmonella Kentucky was also recent
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antimicrobial resistance in typhoidal and nontyphoidal salmonellae
Parry, C. M., & Threlfall, E. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32830f453a · Cited by 292
Le Hello, S., Hendriksen, R. S., Doublet, B., Fisher, I., Nielsen, E. M., Whichard, J. M., Bouchrif, B., Fashae, K., Granier, S. A., Jourdan-Da Silva, N., et al. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir409 · Cited by 277
Self-citationHighly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study
Le Hello, S., Harrois, D., Bouchrif, B., Sontag, L., Elhani, D., Guibert, V., Zerouali, K., & Weill, F.-X. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70124-5 · Cited by 186
Self-citationLe Hello, S., Bekhit, A., Granier, S. A., Barua, H., Beutlich, J., Zając, M., Münch, S., Sintchenko, V., Bouchrif, B., Fashae, K., et al. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00395 · Cited by 154
Self-citation
Metadata
- Authors
- Collard, J.-M., Place, S., Denis, O., Rodriguez-Villalobos, H., Vrints, M., Weill, F.-X., Baucheron, S., Cloeckaert, A., Struelens, M., & Bertrand, S.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-21
- Volume
- 60
- Issue
- 1
- Pages
- 190-192
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2005673890
- Cited by
- 60
- References
- 0
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure. https://app.cochat.ai/papers/10.1093/jac/dkm114
- The paper
- Collard, J.-M., Place, S., Denis, O., Rodriguez-Villalobos, H., Vrints, M., Weill, F.-X., Baucheron, S., Cloeckaert, A., Struelens, M., & Bertrand, S. (2007). Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkm114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.